Showing results (171-180 of 193) with videos related to
Sort By:
Pageof 20
International Journal of Clinical Oncology|February 4, 2024
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) studyHasan Çağrı Yıldırım, Yasin Kutlu, Emel Mutlu, et al.The Lancet. Healthy Longevity|March 24, 2026
Prediction models for overall survival and all-cause mortality risk in older adults with cancer: a systematic reviewPauline Duquenne, Gabor Liposits, Cassandra O Vonnes, et al.Journal of Clinical Medicine|January 28, 2026
Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung CancerAyse Nuransoy Cengiz, Oktay Bozkurt, Muhammet Cengiz, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 17, 2025
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)Nargiz Majidova, Sendag Yaslıkaya, Maral Martin Mıldanoglu, et al.Medicine|November 14, 2023
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from TurkeyArif Akyildiz, Deniz Can Guven, Ahmet Anil Ozluk, et al.Expert Review of Anticancer Therapy|January 9, 2026
Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancerEmel Mutlu Ozkan, Ibrahim Karadağ, Elif Sahın, et al.Scientific Reports|May 8, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patientsMuhammet Cengiz, Oktay Bozkurt, Ayse Nuransoy Cengiz, et al.Journal of Cancer Research and Clinical Oncology|September 1, 2022
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)Mutlu Hizal, Burak Bilgin, Nail Paksoy, et al.Journal of Chemotherapy (Florence, Italy)|September 11, 2024
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinomaHasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, et al.Internal and Emergency Medicine|March 30, 2024
Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)Emre Bilgin, Tuba Demirci Yıldırım, Bahar Özdemir Ulusoy, et al.Pageof 20